← SynDRA
AZELNIDIPINE
SynDRA canonical compound SYN0024838 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | CACNA1C |
| Mechanism of action | calcium channel blocker |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- CACNA1C
- CACNA1D
- CACNA1F
- CACNA1S
Mechanisms of action (all sources)
- CACNA1C BLOCKER
- Voltage-gated L-type calcium channel blocker
- CACNA1S BLOCKER
- CACNA1D BLOCKER
- CACNA1F BLOCKER
- calcium channel blocker
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA3
- SLC6A2
- ESR1
- PDE4D
- NR1I2
- ADORA1
- NR3C1
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- OPRK1
- OPRD1
- HRH3
- OPRM1
- PDE3A
- PGR
- PTGS2
- SCN5A
- SLC29A1
- SLC6A3
- SLC6A4
- TBXA2R
- TDP1
- HTR1A
- HRH2
- ADORA2A
- CCKBR
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- ATXN2
- RPGF3
- RARA
- RAPGEF3
- NR1H4
- NF2L2
- GLI3
- GEMI
- ESRRA
- ESR2
- CP3A7
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- CP19A
- CASP7
- CASP3
- TSHR
Cross-references
Synonyms
- calblock
- CS-905
- Azelnidipino
- Calblock
- CS905
- CS 905
- PV23P19YUG
- DTXCID50120
- azelnidipinum
- RefChem:560476
- Azelnidipine [INN]
- MFCD00865803
- C33H34N4O6
- NCGC00167436-01
- NCGC00167436-02
- CAS-123524-52-7
- UNII-PV23P19YUG
- CCRIS 8650
- ZKFQEACEUNWPMT-UHFFFAOYSA-N
- Calblock (TN)
- RS-9054
- Azelnidipine (Standard)
- AZELNIDIPINE [MI]
- AZELNIDIPINE [JAN]
- Azelnidipine (JP17/INN)
- SCHEMBL49021
- AZELNIDIPINE [MART.]
- AZELNIDIPINE [WHO-DD]
- orb1310917
- SCHEMBL29349688
- CHEBI:31247
- HY-B0023R
- GLXC-05195
- HMS3651D18
- HMS3885M05
- HMS5081G10
- HY-B0023
- Tox21_112440
Look up AZELNIDIPINE in the interactive SynDRA portal →